Shinobi Therapeutics Teams Up with Panasonic to Develop Affordable and Efficient iPS Cell Therapy Manufacturing Technology
Shots:
- Shinobi Therapeutics partners with Panasonic Holding Corps and Kyoto University’s Center for iPS Cell Research and Application (CiRA) to develop affordable and accessible Immune evasive iPS-T cell therapies for broader population
- The partnership aims to leverage Panasonic’s manufacturing expertise to develop a new method to produce iPS-T cell therapies in a closed system process
- With the completion of the first phase of the initial partnership in Apr'25, the companies will release their initial prototype
Ref: Shinobi Therapeutics | Image: Shinobi Therapeutics
Related News:-
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
